BioXcel Therapeutics

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Exscientia is a technology-driven drug design and development company that combines precision design with integrated experimentation to create more effective medicines for patients faster. They operate at the interfaces of human ingenuity, artificial intelligence (AI), automation, and physical engineering, pioneering the use of AI in drug discovery. Exscientia aims to change the underlying economics of drug discovery by rapidly advancing the best scientific ideas into medicines for patients.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

The Institute for Protein Design is a research institute at the University of Washington that uses computational design to create new proteins that solve modern challenges in medicine, technology, and sustainability. The institute's research focuses on developing new protein therapeutics, vaccines, drug delivery systems, biological devices, self-assembling nanomaterials, and bioactive peptides. The institute also has a strong commitment to responsible AI development and has developed a set of principles to guide its use of AI in research.

The Unlearn Platform is an AI-powered platform that streamlines clinical trials by creating digital twins of patients. It offers unparalleled precision in predicting clinical outcomes at future time points. The platform allows for designing smaller, more efficient studies, enhancing decision-making with digital twins, and identifying sensitive clinical outcomes. Unlearn.ai specializes in accelerating clinical development in various fields like neuroscience, immunology, and metabolic diseases.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Intelligencia AI is a leading provider of AI-powered solutions for the pharmaceutical industry. Our suite of solutions helps de-risk and enhance clinical development and decision-making. We use a combination of data, AI, and machine learning to provide insights into the probability of success for drugs across multiple therapeutic areas. Our solutions are used by many of the top global pharmaceutical companies to improve their R&D productivity and make more informed decisions.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

MeDA School is an educational platform dedicated to promoting and nurturing talents in the field of Medical Artificial Intelligence (AI). The platform aims to establish a solid foundation for intelligent and precision medical talent pools in Taiwan and globally. MeDA School facilitates interaction and communication among members of the intelligent medical ecosystem, fostering deep understanding and trust in the operation and tasks of medical AI. The platform offers a blend of virtual and physical courses, inviting domain experts to share cutting-edge knowledge and integrating interdisciplinary knowledge to be practically applied in various fields.

RapidAI is a software platform powered by AI that focuses on aneurysm, pulmonary embolism, and stroke. It offers a range of products and solutions designed to improve patient care and efficiency in hospitals. The technology is clinically rooted and revolutionary, developed by clinicians for clinicians. RapidAI's AI-based platform is known for its speed, scalability, and security, with customization options to meet specific hospital needs. The platform has been trusted by 2,200 hospitals, impacting 90 million lives over 15 years of technological development.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Viz.ai is a leading provider of AI-powered care coordination solutions for healthcare providers. Its comprehensive platform leverages advanced algorithms to analyze medical imaging data, providing real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions cover a wide range of therapeutic areas, including neurology, cardiology, vascular medicine, trauma, and radiology. The company's mission is to improve patient outcomes by closing the gaps between patients, clinicians, and life-saving treatments.

Linus Health is a next-generation digital cognitive assessment platform that enables earlier detection and intervention in brain health. It brings the power of AI to long-trusted cognitive tests, delivering rich insights and actionable clinical guidance. Linus Health's technology has been validated in over 20 published studies and is used by leading organizations to transform their approach to brain health.

Atomwise is an artificial intelligence (AI)-driven drug discovery company that uses machine learning to discover and develop new small molecule medicines. The company's AI engine combines the power of convolutional neural networks with massive chemical libraries to identify new drug candidates. Atomwise has a wholly owned pipeline of drug discovery programs and also partners with other pharmaceutical companies to co-develop drugs. The company's investors include prominent venture capital firms and pharmaceutical companies.

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Beacon Biosignals provides an EEG neurobiomarker platform that is designed to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric diseases. Their platform is powered by machine learning and a world-class clinico-EEG database, which allows them to analyze existing EEG data for insights into mechanisms, PK/PD, and patient stratification. This information can be used to guide further development efforts, optimize clinical trials, and enhance understanding of treatment efficacy.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Intelligencia AI is a leading provider of AI-powered solutions for the pharmaceutical industry. Our suite of solutions helps de-risk and enhance clinical development and decision-making. We use a combination of data, AI, and machine learning to provide insights into the probability of success for drugs across multiple therapeutic areas. Our solutions are used by many of the top global pharmaceutical companies to improve their R&D productivity and make more informed decisions.

Cambrian Copilot is an AI tool designed for researchers and engineers to stay updated with the latest machine learning research. It provides access to over 240,000 ML papers, helps in understanding complex details, and automates literature reviews, making the process more efficient and convenient.

Mnemonic AI is an advanced Customer Intelligence tool that offers AI Personas and Digital Twin of the Customer features. It helps organizations of all sizes better understand individuals and tailor messages to their state of mind. The tool creates buyer personas and virtual twins of customers, all 100% data-driven and fully automated. Mnemonic AI also provides OCEAN Personality Analysis, Schwartz Universal Values, and seamless integrations with data sources.

functime is an AI tool designed for time-series machine learning at scale. It provides a comprehensive set of functions and resources for users to perform forecasting tasks efficiently. With features like scoring, ranking, and plotting functions, functime simplifies the evaluation process of thousands of forecasts simultaneously. Additionally, it offers an AI copilot feature to analyze and compare trends, seasonality, and causal factors in forecasts. The tool also includes detailed API reference documentation for seamless integration.

Kolank is an AI tool that offers a unified API for various AI models, including Generative AI. It provides features such as load balancing, fallbacks, cost and performance metrics. Users can easily access and utilize AI models for tasks like generating text, images, and videos. Kolank simplifies the integration of AI capabilities into applications through its user-friendly interface and comprehensive documentation.

Promptmakr is a platform that facilitates the buying and selling of AI prompts. It serves as a marketplace where users can find and purchase prompts for various AI applications. The platform aims to streamline the process of acquiring prompts, making it easier for developers and AI enthusiasts to access high-quality content to enhance their projects.

StockGPT is an AI-powered financial research assistant that provides knowledge of earnings releases, financial reports, and fundamental information for S&P 500 and Nasdaq companies. It offers features like AI search, customizable filters, industry research, and up-to-date data to help users analyze companies and markets more efficiently.

Google Colab Copilot is an AI tool that integrates the GitHub Copilot functionality into Google Colab, allowing users to easily generate code suggestions and improve their coding workflow. By following a simple setup guide, users can start using the tool to enhance their coding experience and boost productivity. With features like code generation, auto-completion, and real-time suggestions, Google Colab Copilot is a valuable tool for developers looking to streamline their coding process.

Lobe is a machine learning tool that helps users easily train machine learning models and deploy them to any platform. It offers a user-friendly interface for creating image-based datasets and provides starter projects for iOS, Android, web, and REST API development. Lobe aims to simplify the machine learning process for both beginners and experienced developers.

Aitodata.com is an AI-powered data analysis platform that empowers users to extract valuable insights from their data effortlessly. The platform offers a user-friendly interface and advanced algorithms to help users analyze, visualize, and interpret data in a meaningful way. With Aitodata.com, users can streamline their data analysis process, make data-driven decisions, and uncover hidden patterns and trends within their datasets.

Shimoku is an AI application that offers a catalog of AI modules covering the customer lifecycle for marketers and sales teams. It provides AI-driven solutions for ads acquisition, call center operations, lead conversion, client loyalty, and retention. Shimoku's AI technology combines machine learning, explainability AI, and generative AI to predict opportunities, personalize proposals, and optimize marketing strategies. The application caters to various industries such as auto, ecommerce, insurance, retail, SaaS, and more, helping businesses enhance their performance and growth.

Weaviate is an AI-native database designed to bring intuitive AI-native applications to life with less hallucination, data leakage, and vendor lock-in. It offers features like Hybrid Search, Retrieval-Augmented Generation, Generative Feedback Loops, and Cost-performance optimization. Weaviate empowers developers to build AI-native applications with flexible, reliable, open-source foundations, tailored AI infrastructure patterns, and over 1M monthly downloads. The platform is known for its best-in-class hybrid search, integrations with major LLMs, and ease of deployment.

GitBrain is an AI-powered Git client designed for Mac users. It simplifies the Git workflow by offering features such as AI commit messages, code splitting, self code review, auto-detection of projects from favorite IDEs, and a keyboard-friendly design. The application aims to make developers more productive by intelligently handling Git operations and providing a seamless user experience. GitBrain is optimized for Mac performance with a native UI and offers light & dark mode themes for customization.

Chessvision.ai is an AI-powered eBook reader designed to enhance the study experience of chess enthusiasts. The application utilizes Artificial Intelligence and Computer Vision to make chess eBooks interactive, allowing users to analyze positions, add comments, search online databases, watch YouTube videos, and analyze with the engine. It is a highly recommended tool for players of all levels looking to improve their chess skills.

ThirdAI is a production-ready AI platform designed for enterprises, offering a comprehensive solution for building AI applications without the need for extensive proof-of-concept cycles or manual fine-tuning. The platform provides enterprise-grade productivity tools, document search and retrieval, content creation, FAQ bots, customer live support, hyper-personalization, risk and compliance features, fraud detection, anomaly detection, and PII/sensitive data redaction. ThirdAI allows users to bring their business problems, apply them to data, and compose AI applications effortlessly. The platform supports no-code customization, turnkey deployment, and user engagement data for best-in-class accuracy.

Susterra is an advanced analytics platform for Public Finance stakeholders, aiming to catalyze urban development by providing powerful insights. The platform integrates leading practices from academia, leverages public data growth, and utilizes technology innovations like ML and AI to enable issuers to make suitable choices for the growth of the Municipal Bond Market and Smart Cities development in the United States.

Collective[i] is an AI-powered platform that helps businesses optimize their sales processes by leveraging AI technology to forecast sales, improve productivity, and grow revenue. The platform provides insights, automates tasks, and enhances decision-making to drive revenue optimization. Collective[i] offers applications such as Intelligent WriteBack™ for data cleansing, C[i]™ for Sales for buyer-centric selling, and Intelligence.com® for surfacing connections. The platform prioritizes enterprise-level security and privacy to ensure the confidentiality and integrity of business information.

The AI SDK is a free open-source library designed to empower users to build AI-powered products. It offers a unified provider API, generative UI capabilities, framework-agnostic support, and streaming AI responses. The SDK is trusted by builders at OpenAI, Claude, and Hugging Face, and has received positive feedback for its ease of use and efficiency in building AI features within minutes.

DecodeAI is an experimental concept for an automatic blog about AI, generated by AI and curated by humans. The blog mainly focuses on AI-related GitHub open-source repositories but is not limited to that. It features tools like Cody, an AI coding assistant, Jan, an open-source offline AI desktop tool, and Open Interpreter, which allows language models to execute code locally. DecodeAI aims to provide valuable insights and resources in the field of artificial intelligence.

AnyAPI is an AI tool that allows users to easily add AI features to their products in minutes. With the ability to craft the perfect GPT-3 prompt using A/B testing, users can quickly generate a live API endpoint to power their next AI feature. The platform offers a range of use cases, including turning emails into tasks, suggesting replies, and accessing plain text JSON. AnyAPI is designed to streamline the integration of AI capabilities into various products and services, making it a valuable tool for developers and businesses seeking to enhance their offerings with AI technology.